The Canadian cannabis industry has been a pioneering sector offering some of the most direct growth in the global space. However, due to recent warning signs and lacking results, investors are asking themselves: Are Canadian marijuana stocks a good investment?

Following a shift in investment attention to marijuana stocks in the US, the biggest scandal in the Canadian cannabis market leaving thousands of medical patients without medicine, the burgeoning hemp-derived cannabidiol (CBD) US market attracting a bulk of Canadian leaders into the space and the general downward projection on its market, the often touted Canadian leadership and first mover status has recently been put into question.

Here the Investing News Network (INN) offers investors with some commentary on the state of publicly traded Canadian cannabis shares, the entire market and its path forward.

Are Canadian marijuana stocks a good investment? Volatile swings

In the run-up to the legalization of marijuana for recreational use in Canada — which joined an existing medical marijuana program in the country — cannabis stocks gained an increased notoriety thanks to volatile swings.

These companies gained a reputation as stocks to buy for an untapped entry into marijuana growers and a brand new industry in the marijuana business.

Canadian leaders such as Canopy Growth (NYSE:CGC,TSX:WEED) and Aurora Cannabis (NYSE:ACB,TSX:ACB) blazed a crucial path by reaching senior US listings on the New York Stock Exchange (NYSE). Since Canopy Growth started trading on the NYSE in May 2018, six other Canadian producers have joined with US listings.

While these marijuana companies — alongside other leaders in the Canadian industry — have moved ahead with novel recreational supply agreements with provincial partners, the medical cannabis space has seen advancements in availability and acceptance.

The swings have stabilized as the industry moved past its initial legalization craze stage. Now, according to one marijuana stocks expert, investors will actually start to see performance based on merit and realistic metrics.

“We’re seeing a fairly big differentiation between companies that are putting out good numbers and those that aren’t,” Greg Taylor, chief investment officer with Purpose Investments previously told INN. “I think the big shift that had to come to the sector and it seems like it’s finally here in the Canadian investor.”

Taylor also acts as the portfolio manager for the Purpose Marijuana Opportunities Fund (NEO:MJJ).

Following the first wave of rush interest for marijuana stocks — driven mainly by retail investors — a variety of companies moved forward with public listings based on the merit of being a marijuana firm.

Taylor told INN he is expecting to see the number of company failings and shutdowns to expand moving forward as the Canadian cannabis industry continues its maturity process.

Many experts have agreed an uptick in mergers and acquisitions activity would take place in the market. 2018 already proved to have a significant increase in these transactions for the industry.

The portfolio manager said some Canadian mid-tier public cannabis companies have failed to differentiate themselves enough from the rest of the pack, which could lead to investing issues moving forward.

“Those companies seemed to have completely lost the attention of investors and are going to have a hard time raising equity going forward until they can put up some really good numbers and get back in the (good graces) of investors,” Taylor said.

Following significant layoffs for his firm, John Prentice, president and CEO of Ample Organics, a private tech company offering seed-to-sale software to the cannabis industry, said his company has faced a roadblock trying to raise capital.

“It’s been an interesting time in the cannabis industry. There’s a lot … of turmoil happening. I think that capital is drying up in the space, and really Ample is a bellwether for everything else that’s going on in the industry,” Prentice told BetaKit.

Charles Taerk, president and CEO of Faircourt Asset Management, told INN he also expects to see an increase in failing companies. He said this is due to the limited size of the population in Canada not meeting the needed demand for the amount of production available in Canada.

“I think in this case there will be less consolidation (in cannabis) because we won’t need as much cultivation and so some businesses, unfortunately, may go out of business,” said Taerk.

Are Canadian marijuana stocks a good investment?Attention shifts to US market

While the success of legalization in Canada enticed many investors, the growth sector for cannabis investment has moved below the border.

Companies with assets in the fractured US legal cannabis market, also known as multi-state operators (MSOs), began picking up the attention of investors offering results and the promise of quick expansion across the board.

In 2019, there’s been a recognized investment shift towards these MSOs as investors attempt to capture the upside of these companies and take full advantage of a discount in trading compared to its Canadian counterparts.

That discount may soon disappear, according to one cannabis analyst.

Matthew Pallotta, equity research analyst at Echelon Wealth Partners, told INN he expects to see that price difference adjust once critical policy development moves forward in the US.

“I think the discount is probably going to close regardless once people start seeing the revenue numbers these businesses are putting up,” Pallotta told INN.

Pallotta sees the shift in investment as a growing trend that will not change.

“I still think that there’s definitely going to continue to be more capital moving into the names in the US for sure. No question about that,” he told INN. “That trend I think is not one that’s going to reverse it’s just going to keep growing stronger.”

There’s been easy access to exposure of the US market since two public Canadian exchanges offer listing services for companies operating assets in the US marijuana industry.

These cannabis stocks offer entry into robust state medical marijuana programs alongside rising recreational marijuana sales.

“Clearly we are moving now in a period where there was a lot of focus on US marijuana firms,” Jos Schmitt, president and CEO of the NEO Exchange — which is one of those Canadian exchanges — told INN. “There’s a lot of interest in that space.”

The Canadian Securities Exchange (CSE), the other Canadian exchange that elected not to block US marijuana companies from listing, has seen a significant flow of financing and listings thanks to its bet on these companies.

During a conference call with investors in March, Tilray (NASDAQ:TLRY) CEO Brendan Kennedy said the company is now focused on deploying its capital in the most important markets for its growth: the US and Europe.

Since then, the producer has expanded its presence in the European industry, now including exports from its central facility in Portugal.

Are Canadian marijuana stocks a good investment? Investor takeaway

The introduction of marijuana edibles, the expansion of retail stores across the country and the expanding medical marijuana market could help boost in the performance seen by Canadian marijuana companies.

Despite any adjustment in investor sentiment, Pallota told INN Canadian players have the support from institutional money. “I don’t think you’re going to see a wholesale shift out of Canadian names immediately or anything like that,” he said.

Similarly, Taylor echoed the sentiment and said investors can still find some “really good” companies to invest in.

The investing executive pointed to the shares of some of the big market cap producers such as Canopy Growth, Aurora Cannabis, Organigram Holdings (NASDAQ:OGI,TSXV:OGI) and HEXO (NYSEAMERICAN:HEXO,TSX:HEXO) as having a lot of potential for runs available to investors.

Taylor also highlighted the companies involved in the emerging extraction market as stocks to watch since these companies produce the cannabis oil needed for the upcoming sales of edible and infused recreational marijuana products.

According to the expert, these companies having identified a critical need of the marijuana industry, especially as the Canadian market nears the second stage of marijuana legalization.

“As we move into the beverages and edibles in the second half of the year, I think we’re going to be way more focused on extraction so the extraction play is going to be interesting,” he said.

These recreational products will test the appetite of the Canadian consumer as many companies have increased their production capacity and added the ability to produce novelty infused recreational cannabis drinks.

While for some it may appear as though investing in Canadian marijuana stocks focused on legal marijuana products have reached the end of the line for growth, experts still expect to see potential in for investors.


Want more details? Check out these articles for more INNdepth coverage.

Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the final tranche of its oversubscribed non-brokered private placement for aggregate gross proceeds of approximately $4,730,000 (the “Offering”).

The Corporation issued a combined total of 39,409,346 units (each a “Unit“) at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.

Keep reading... Show less

Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands) announces that the letter of intent with Franchise Cannabis Corp. (“FCC”), previously announced in January, has been terminated. The previously announced European joint venture with FCC will continue and allow the Company to launch and tailor its products to European consumer demands

In connection with termination of the merger transaction with FCC, the Company has agreed to pay FCC $100,000 in cash and to issue FCC 5,000,000 common shares of the Company at a deemed value of $0.05 per share. The common shares will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Keep reading... Show less

Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.

Keep reading... Show less

Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).

Keep reading... Show less

Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.

Keep reading... Show less